Hospital quality, patient risk, and Medicare expenditures for cancer surgery by Shubeck, Sarah P. et al.
A
cc
ep
te
d 
A
rt
ic
le
Hospital Quality, Patient Risk, and Medicare Expenditures for Cancer Surgery 
Sarah P. Shubeck, MD1,2, Jyothi R. Thumma, MPH2, Justin B. Dimick, MD, MPH2,  
Hari Nathan, MD, PhD2 
 
1National Clinician Scholars Program 
2Department of Surgery, University of Michigan 
 
Running Title: Hospital Quality and Expenditures for Surgery 
 
Corresponding Author and requests for reprint:  
Sarah Shubeck, MD 
NCRC Building 14, 2800 Plymouth Road 
Ann Arbor, MI 48109 
Telephone: (269)873-0451 
Fax: (734)647-3301 
Email: sponto@med.umich.edu 
 
 
 
Acknowledgements of Research Support: 
- S.S. is supported by the National Clinician Scholars Program.  
- H.N. is supported by funding from the Agency for Healthcare Research and Quality, 
K08HS024763. 
 
Conflicts of Interest and Source of Funding:  Dr. Dimick is a CoFounder of ArborMetrix, a 
company that makes software for profiling hospital quality and efficiency. For the remaining 
authors none were declared. 
 
Author Contributions: 
Sarah P Shubeck: Conceptualization, Methodology, Writing – Original Draft, Writing – 
Review & Editing  
Jyothi R. Thumma: Data Curation, Formal Analysis, Writing – Review & Editing 
Justin B. Dimick: Conceptualization, Writing – Review & Editing  
Hari Nathan: Conceptualization, Funding acquisition, Methodology, Writing – Original 
Draft, Writing – Review & Editing 
 
 
Precis for use in the Table of Contents: Total episode expenditures for cancer resections were 
lower when care was delivered in low complication, high quality hospitals. These expenditure 
differences were particularly large for high risk patients, suggesting a potential benefit of 
selective referral for this high cost population.   
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Abstract  
Background: Surgical resection is a cornerstone of curative-intent therapy for patients with solid 
organ malignancy. With increasing attention paid to costs of surgical care, there is a new focus 
on variation in the cost of cancer surgery. We sought to evaluate the potential interactive 
relationship between hospital quality and patient risk on expenditures for cancer resections. 
Methods: Using 100% Medicare claims data for 2010-2013, we identified patients aged 65-99 
years undergoing cancer resection. We calculated Medicare payments for the “surgical episode” 
from index admission through 30 days after discharge.  Risk- and reliability-adjusted hospital 
rates of serious complications and mortality within 30 days of index operation were assessed to 
categorize high and low quality hospitals. 
Results: There was no difference in patient characteristics between the highest and lowest 
quality hospitals. There were substantial increases in expenditures for procedures performed at 
the lowest quality hospitals for each procedure. Increased expenditures at lowest quality 
hospitals were found for all patients but were largest for the highest risk patients. At low quality 
hospitals, low risk patients undergoing pancreatectomy had payments of $29,080 versus high 
risk patients with average payments of $62,687, a difference of $17,762 per patient episode.  
Conclusions: We found that total episode expenditures for cancer resections were lower when 
care was delivered in low complication, high quality hospitals. Expenditure differences were 
particularly large for high risk patients, suggesting that selective referral of high risk patients to 
high quality centers may be an effective strategy to optimize value in cancer surgery. 
Keywords: Cancer Resection, Hospital Quality, Surgical Expenditures, Cost Containment, 
Episode Expenditures 
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Introduction 
Much attention has focused on the costs of cancer care, as estimates predict a total of $173 
billion in annual spending for the care of patients with cancer by 2020 [1]. The cost of 
chemotherapy administration has garnered particular interest and has been the target of 
bundled payment programs such as the Oncology Care Model for Medicare patients [2]. 
However, surgical resection is also a cornerstone of curative-intent therapy for patients with 
solid organ malignancy and can be particularly resource-intensive. To date, surgery for cancer 
has not been a primary target of cost containment efforts, but other surgical procedures have 
been [3]. Given the tremendous variation in cost of cancer surgery [1, 4, 5], future cost 
containment efforts for cancer care are likely to include surgical cancer care [6-8]. 
 
The cost of surgical resection varies by as much as 130% between hospitals [5]. Because 
inpatient surgical costs are largely driven by the occurrence of postoperative complications [9-
13], cost variation is intimately related to hospital quality [14]. Patient age, comorbidities, and 
functional status may also impact the costs of care by affecting both a patient’s likelihood of 
experiencing a complication and the difficulty of subsequent recovery. Previous studies have 
generally adjusted for such patient factors in order to focus on hospital comparisons [8]. 
However, high-risk and low-risk patients are likely to fare differently even at the same hospital. 
There may be an interactive effect of hospital quality and patient risk on hospital expenditures, 
but no prior work has addressed this question in patients undergoing cancer surgery.  
 
To better understand the collective effect of patient risk and hospital quality on surgical costs, 
we studied elderly Medicare beneficiaries undergoing any of three elective cancer resections: 
colectomy, lung resection, or pancreatectomy. We assessed hospital variation in risk-adjusted 
Medicare payments for the entire episode of surgical care. We also stratified patients based on 
Page 3 of 21 Cancer
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
4 
 
their risk for post-operative complications, regardless of hospital effects. Finally, we quantified 
the interactive effect of hospital quality and patient risk in determining the cost of cancer 
surgery.  
 
Methods 
Data Source   
From the Centers for Medicare and Medicaid Services, we used data from the Medicare 
Provider Analysis and Review (MEDPAR) File from 2010-2013. We used the International 
Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes to identify 
patients undergoing elective colectomy, lung resection, and pancreatectomy for diagnoses of 
malignancies. We included patients aged 65-99 years with continuous Part A & B non-Health 
Maintenance Organization Medicare coverage for 3 months before and 6 months after the 
surgical procedure of interest. We excluded patients with a preoperative length of stay greater 
than one day and those undergoing emergent or urgent procedures in order to capture patients 
undergoing elective resections. Hospitals were identified by provider number in the MEDPAR 
file, and additional hospital information was obtained from the American Hospital Association 
Annual Survey [15].  
 
Hospital Quality Assessment  
We used rates of serious complications within 30 days of index operation as the primary 
outcome to classify high and low quality hospitals. We first identified post-operative 
complications using ICD-9-CM codes for the following categories of complications: anastomotic, 
cardiac, genitourinary, hemorrhagic, neurologic, obstruction, postoperative shock, pulmonary, 
splenic injury, thromboembolic, wound infection, and reoperation [16]. As in previous work, we 
defined “serious complications” as those associated with hospital length of stay greater than the 
75th percentile for each procedure performed [10, 15, 17]. In order to further validate our 
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assignments as high and low quality assessments, we determined the 30-day mortality rates for 
the hospital quintiles.  
 
We then performed risk and reliability adjustment of the hospital based rates of complications as 
described below. Hospitals were sorted into quintiles based on these adjusted complication 
rates. The hospitals in the lowest quintile of complications were labelled “high quality hospitals” 
and those in the highest quintile of complications were labeled as “low quality hospitals.”  
 
Patient Risk Assessment 
We stratified patients by risk using a model to predict likelihood of sustaining a postoperative 
complication. Patient comorbidity information was captured for conditions present on admission 
for the index hospitalization. Those in the highest quintile of risk for perioperative complications 
were labele  as “high risk” and those in the lowest quintile of risk were labeled as “low risk” for 
comparison. We then compared impact of patient preoperative risk of developing a 
postoperative complication on total expenditure payments in hospitals of varying quality levels.  
 
Payment Data 
We used Medicare payment data from the MEDPAR file to accurately reflect episode 
expenditures. Total episode payments included the index procedure with associated admission 
up to 30 days after discharge date. We included data from inpatient, outpatient, carrier, home 
health, skilled nursing facility, and long stay hospital. We then collapsed this payment data into 
four categories: index hospitalization, readmissions, physician services, and post-acute care 
services. Index hospitalization payments includes index admission and post-operative care 
during the initial hospital episode and readmission payments cover any additional inpatient 
admissions during the 30 days after index operation. Physician services payments include 
reimbursement for services provided by physicians or other health professions. Post-acute care 
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services payments include post-discharge rehabilitation services, post-discharge admission to 
skilled nursing facilities, and post-discharge admission to long stay hospitals.  
 
Payments were price standardized to account for variation in Medicare reimbursement based on 
geography and care setting. Methods for price standardization were based on techniques 
described by the Dartmouth Institute [18, 19].  
 
Statistical Analysis 
Risk adjustment of complication rates was performed using a multivariable logistic regression 
model accounting for patient age, sex, race, comorbidities, [20, 21] and operation type to 
calculate a risk adjusted rate of complications for each hospital. Additionally, we included 
adjustments for minimally invasive techniques including laparoscopic colectomy and 
thoracoscopic lung resection. We also included year of operation in the regression model to 
account for any possible secular trends. Subsequently, we used hierarchical modeling 
techniques to “reliability adjust” outcomes by accounting for statistical noise [22]. Our final 
assignment of hospitals to quality quintiles was based on the resulting risk- and reliability-
adjusted rates of serious complications.  
 
Hospital and patient characteristics at high-quality and low-quality hospitals were compared 
using chi-square and Wilcoxon rank-sum tests. We compared both total Medicare payments as 
well as individual payment components including index hospitalization, readmissions, physician 
services, and post-acute care services for the entire surgical episode.   
 
As in previous analyses [5, 10, 17, 23, 24], we used predicted total payment for each patient as 
the risk-adjusted payment using a linear mixed model that was controlled for patient age, 
gender, race and 29 Elixhauser comorbidities. We calculated the average risk-adjusted payment 
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for each hospital and then reported the average of these risk-adjusted hospital payments by 
quality quintiles. We also calculated average risk-adjusted payment by risk groups within each 
hospital to report payments by risk groups and hospital quality. 
 
Results 
We analyzed data on 87,369 patients undergoing colectomy at 3,576 hospitals, 66,470 patients 
undergoing lung resection at 1,904 hospitals, and 8,423 patients undergoing pancreatectomy at 
747 hospitals (Table 1).  
 
Hospital Characteristics 
Hospitals were characterized according to their risk and reliability adjusted complication rates. 
For the three procedures analyzed, the lowest quality hospitals had complication rates that 
ranging between 1.5-2.2 times higher than those facilities in the highest quality quintile. As 
described above, we determined 30-day rates of mortality for each of the procedures at the high 
and low quality hospitals after their quality designation. For each procedure, the mortality rate 
was statistically significantly higher at the low quality institutions (Table 2).  
 
High and low quality hospitals had several differences in their characteristics for each of the 
procedures evaluated. Low quality hospitals performing colectomy were more often teaching 
hospitals and larger than high quality hospitals, whereas low quality hospitals performing 
pancreatectomy were more often smaller with fewer operating rooms than high quality 
institutions. For lung resections, low quality hospitals were smaller in terms of bed size and 
number of operating rooms, but high quality hospitals were more often teaching institutions 
(Table 2).  
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Patient Characteristics  
There was no significant difference in age for patients undergoing any of the three procedures 
evaluated, but there were differences in other demographics when comparing patients 
undergoing resections at highest and lowest quality hospitals (Table 3). The total number of 
patient comorbidities were not different for pancreatectomy and colectomy between high and 
low quality hospitals, but those undergoing lung resection at the low quality hospitals were more 
often multimorbid with two or more comorbidities (78% vs 74%, p<0.0001) (Table 3).  
 
High versus Low Quality Hospital Expenditures  
Procedures performed at low quality hospitals versus high quality hospitals resulted in 16%-30% 
higher total 30-day episode expenditures for all three procedures. For average risk patients 
undergoing colectomy, low quality hospitals generated substantially higher episode 
expenditures than high-quality, low complication hospitals ($24,406 vs $20,992, p <0.0001). 
Larger increases in total episode expenditures differences between low and high quality 
hospitals were found in patients undergoing lung resection ($27,638 vs $21,282, p <0.0001) and 
pancreatectomy ($45,731 vs $35,149, p <0.0001).  
 
We found increases in rates of post-acute care services for patients undergoing colectomy and 
lung resection at low quality hospitals (68% vs 65% for colectomy, 68% vs 65% for lung 
resection), but similar rates between high and low quality hospitals after pancreatectomy. 
Regardless of rates of post-acute care services, low quality hospitals generated increased 
expenditures ($1,024 for colectomy, $1,643 for lung resection, $1,577 for pancreatectomy). 
Similarly, low quality hospitals had higher rates of readmission for each of the three procedures 
(colectomy: 13% versus 12%; lung resection: 13% versus 12%, pancreatectomy: 25% versus 
22%). When patients were readmitted, they accrued similar excess expenditures for their 
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readmissions regardless of the quality of the hospital where their index procedure was 
performed (Table 4).  
 
Increased utilization of post-acute care services and increased rates of readmissions 
contributed to the increased episode payments, but the dominant driver of excess expenditures 
at low quality hospitals was payment for the index hospitalization. We found that index 
hospitalization expenses generated 62-79% of the increase in expenditures across procedures 
for low versus high quality hospitals (Table 4). For example, a patient undergoing colectomy at a 
high quality hospital had an average index hospitalization payment of $14,141 whereas a similar 
patient at a low quality hospital generated an index hospitalization payment of $16,255, resulting 
in an excess of $2,114 per colectomy. More substantial increases were noted for patients 
undergoing lung resection ($4,154) and pancreatectomy ($8,378) at low quality hospitals.  
 
Interaction of Hospital Quality and Patient Risk 
Next, we sought to explore whether the impact of hospital quality on expenditures differed 
depending on patient risk. Low quality hospitals generated excess expenditures for all patient 
risk groups. For example, low risk patients undergoing colectomy at low quality hospitals 
generated $17,001 compared to $15,423 per 30-day episode at high quality institutions. 
Similarly, we found excess expenditures for low risk patients undergoing lung resection ($3,797) 
and pancreatectomy ($4,357) at low quality institutions.  
 
Although all patient risk groups incurred higher expenditures at low quality hospitals, the impact 
on expenditures for high risk patients was particularly pronounced. For example, low risk 
patients undergoing pancreatectomy incurred 17% higher episode payments at low quality 
hospitals ($29,080 versus $24,723, p=<0.0001). High risk patients undergoing pancreatectomy 
incurred a 40% increases in total episode payments at low quality versus high quality hospitals 
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($62,687 versus $44,925, p=<0.0001). The episode payment increase for high risk patients 
receiving care at low vs high quality hospitals was significantly higher than low risk patients in 
similar comparisons (40% vs. 17%, p=<0.0001). Similar results were found for patients 
undergoing colectomy, with increased expenditures at low quality hospitals (10% increased 
expenditures for low risk patients, 18% increased expenditures for high risk patients, 
p=<0.0001) and lung resection (24% increased expenditures for low risk patients, 29% 
increased expenditures for high risk patients, p=<0.0001) (Table 5, Figure 1).  
 
Discussion 
Poor hospital surgical quality, as manifested by high complication rates, is directly related to 
excess costs of care. Previous studies have consistently shown that, for many surgical 
procedures [13, 14] and for cancer surgery in particular [9], the occurrence of postoperative 
complications drives expenditures in the inpatient setting and beyond. The notion that certain 
high risk patients may be both more prone to complications and experience a more difficult 
recovery once they occur has clinical face validity, but has not been explored in this context. In 
this analysis, we found that cancer resections performed at low quality hospitals generate 
substantial excess expenditures for all patients. However, excess expenditures were particularly 
pronounced when high risk patients underwent surgery at low quality hospitals. As health 
systems and policymakers attempt to identify targeted interventions aimed at managing the 
costs of healthcare, a focus on high risk patients receiving care at low-quality institutions may be 
warranted. 
 
In spite of the fixed payment structure of the DRG model, we found that there is wide variation in 
payments for cancer surgery. Whether due to higher reimbursement for increased numbers 
patients meeting criteria for outlier payments due to longer hospital stays or postoperative 
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complications, this highlights large potential savings in the delivery surgical cancer care. As we 
describe, a substantial amount of this variation is attributable to preexisting cost differences 
between hospitals. For example, we found that high risk patients would disproportionately 
benefit from directed referral to high quality centers for oncologic resection. Previous work has 
suggested selective referral for uncommon procedures based on volume or quality rankings to 
improve outcomes and reduce costs of surgical care [25, 26]. This analysis highlights a 
particular high risk subset of the surgical population that would be most likely to benefit from 
referral with respect to cost for oncologic resection. Identifying this portion of the surgical 
population can provide a more realistic strategy for selective referral as suggesting referring all 
patients is not a practical strategy. This immediate solution may improve outcomes and 
healthcare spending for these highest risk patients, while ongoing quality improvement 
initiatives at low quality, higher cost hospitals could expand the network of high quality hospitals 
for all patients. 
 
There are several limitations to this analysis. First, this analysis assessed patient risk using 
administrative data, which may incompletely capture some aspects of pre-operative risk such as 
performance status and frailty. Second, we adopted a payer’s perspective on surgical 
expenditures by assessing actual Medicare reimbursements for care. Our analysis does not 
address other perspectives on health care cost, such as utilization and opportunity cost within a 
health system. We used 30-day episode payments, which may not fully represent the longer 
term care received after surgical resection. We focused on elderly Medicare beneficiaries 
undergoing three surgical resections for cancer diagnoses, and therefore our findings may not 
be generalizable to younger populations of patients, those undergoing other cancer resections 
not included in our analysis, and those with private insurance. Finally, we did not include cancer 
stage in our analysis or risk adjustment as this is not accurately reflected in the Medicare 
Provider Analysis and Review (MEDPAR) File from 2010-2013. As these patients all underwent 
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resection, they were likely diagnosed with localized disease. Prior work has demonstrated that 
adding cancer specific staging to outcomes assessments using claims data shows that there is 
not much benefit in measuring performance [27]. Although a similar analysis has not been done 
for surgical costs, we find it highly improbable that cost differences identified are due to 
differences in cancer stage.  
 
Conclusions 
In summary, we found that there is a significant interaction between hospital quality and 
preoperative patient risk that drives payments for cancer resections. The excess expenditures 
for procedures performed at low quality hospitals is exaggerated for high risk patients. This 
analysis demonstrates that those patients at highest risk for postoperative complications may 
stand to benefit most substantially from cost containment strategies including selective referral 
to high quality centers. 
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Figure Legend 
Figure 1  
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Table 1: Patient Characteristics   
 Colectomy Lung Resection Pancreatectomy 
Number of Pts, n  87,369 66,470 8,423 
Age, years 77.4 74.3 74.4 
Male, % 45.9 48.7 51.35 
White, %  88.7 91.3 88.7 
Comorbidities, %    
      0-1 25.8 24.87 21.88 
      2 24.7 26.57 24.77 
      ≥3 49.6 48.56 53.35 
Laparoscopic/ 
Thoracoscopic 
Operation, % 
40.0 46.6 N/A 
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Table 2: Hospital Characteristics (high/low quality) 
 Colectomy Lung Resection Pancreatectomy 
 All 
Hospital
s  
High 
Quality 
Hospitals 
Low 
Quality 
Hospitals 
p-value All 
Hospitals  
High 
Quality 
Hospitals 
Low 
Quality 
Hospitals 
p-value All 
Hospitals 
High 
Quality 
Hospitals 
Low 
Quality 
Hospitals 
p-value 
No. of Hospitals 3,576 716 715  1,904 381 380  747 150 149  
No. of Patients  87,369 25,070 25,913  66,470 25,962 12,797  8,423 3,873 1,662  
Bed Size             
      <250 40.9 39.2 31.6 
<.001 
21.4 17.1 24.0 
0.025 
8.7 6.7 9.3 0.040 
      250-500 36.1 40.2 38.3 39.7 38.7 48.1 32.0 24.1 33.5  
      >500  23.0 20.6 30.2 38.9 44.2 30.0 59.3 69.2 57.2  
Teaching Hospital % 54.7 54.3 64.2 <.001 92.6 76.7 60.8 0.002 90.7 94.2 91.4 0.128 
Annual total inpatient 
surgical volume 
5,446 5,146 6,748 <.0001 8,121 9,653 6,226 <.0001 11,914 11,492 13,736 0.0083 
Annual total outpatient 
surgical volume 
8,276 8,095 9,956 0.003 11,544 14,346 8,683 <.0001 15,640 12,690 18,642 0.0088 
Annual total surgical 
volume 
13,723 13,240 16,703 0.0002 19,666 23,999 14,908 <.0001 27,554 24,182 32,378 0.0052 
Annual Average 
Procedure Specific 
Volume 
15.7 17.0 17.0 0.915 33.2 49.4 17.6 <.0001 14.7 19.5 8.8 <.0001 
Length of Stay (days) 7.2 6.4 8.1 <.0001 6.9 5.9 8.9 <.0001 12.8 11.0 16.2 <.0001 
Risk-Reliability 
Adjusted Complication 
Rate, %  
10.2 8.4 12.3 <.0001 8.9 6.3 13.8 <.0001 13.4 10.9 17.8 <.0001 
Mortality Rate  4.0 3.8 4.2 <.0001 2.8 2.6 3.2 <.0001 3.8 3.6 4.2 <.0001 
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Table 3: Patient Characteristics at high vs low quality hospitals 
 Colectomy Lung Resection Pancreatectomy 
 High Quality 
Hospitals 
Low Quality 
Hospitals 
p-value High Quality 
Hospitals 
Low Quality 
Hospitals 
p-value High Quality 
Hospitals 
Low Quality 
Hospitals 
p-value 
Number of Pts 26,070 25,913  25,962 12,962  3,873 1,662  
Age 77.3 77.4 0.004 74.4 74.2 0.001 74.2 74.6 0.025 
Male, % 45.9 46.2 0.508 47.6 50.6 <.0001 51.9 51.1 0.578 
White, %  89.6 87.6 <.0001 92.1 91.6 0.105 90.1 87.4 0.005 
Comorbidities, %          
     0-1 25.4 25.1 0.447 26.4 21.9 <.0001 21.7 21.3 0.730 
     2 24.1 25.1 0.007 27.3 25.2 <.0001 25.4 24.0 0.264 
     ≥3 50.5 49.8 0.095 46.3 52.9 <.0001 52.9 54.8 0.212 
Laparoscopic/ 
Thoracoscopic Approach 
40.8 41.7 0.031 52.1 39.0 <.0001 N/A N/A N/A 
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Table 4: Payments for Procedures at High and Low Quality Hospitals   
  Low Quality Hospitals High Quality Hospitals Difference in Payment P-Value  
Colectomy  
 Total Episode $24,406 $20,992 $3,414 <.0001 
 Index Hospitalization $16,255 $14,141 $2,114 <.0001 
 Physician Services $3,562 $3,135 $427 <.0001 
 Readmission (when present)  $10,171 $10,662 -$491 0.194 
 Post-Acute Care Services (when present)  $4,735 $3,711 $1,024 <.0001 
Lung Resection 
 Total Episode $27,638 $21,282 $6,356 <.0001 
 Index Hospitalization $18,961 $14,808 $4,154 <.0001 
 Physician Services $4,708 $4,012 $696 <.0001 
 Readmission (when present)  $11,998 $10,516 $1,482 0.033 
 Post-Acute Care Services (when present)  $5,022 $3,378 $1,643 <.0001 
Pancreatectomy 
 Total Episode $45,731 $35,149 $10,582 <.0001 
 Index Hospitalization $31,049 $22,671 $8,378 <.0001 
 Physician Services $7,140 $6,264 $877 0.001 
 Readmission (when present)  $11,290 $10,698 $592 0.570 
 Post-Acute Care Services (when present)  $6,313 $4,736 $1,577 0.001 
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Table 5: High and Low Risk Patients in High and Low Quality Hospitals  
 Patient Risk Low Quality Hospital High Quality Hospital Difference in Payment P-Value  
Colectomy High Risk $35,708 $30,394 $5,314 <.0001 
 Low Risk $17,001 $15,423 $1,578 <.0001 
Lung Resection High Risk $39,735 $30,908 $8,827 <.0001 
 Low Risk $19,863 $16,066 $3,797 <.0001 
Pancreatectomy High Risk $62,687 $44,925 $17,762 <.0001 
 Low Risk $29,080 $24,723 $4,357 <.0001 
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